Results 31 to 40 of about 6,391 (215)

Application of the quality by design (QbD) approach for the development of composition of extended-release tablets based on sodium 4,4’-(propanediamido)dibenzoate

Разработка и регистрация лекарственных средств
Introduction. Pharmaceutical development is a complex work, the main goal of which is to achieve the quality target product profile (QTPP). QTPP is formulated on the basis of a whole set of requirements for the drug, including pharmacopoeial, consumer ...
Yu. M. Kotsur, E. V. Flisyuk, I. A. Narcevich   +2 more
doaj   +1 more source

Bioactive Components from Qingwen Baidu Decoction against LPS-Induced Acute Lung Injury in Rats

Molecules, 2017
Qingwen Baidu Decoction (QBD) is an extraordinarily “cold” formula. It was traditionally used to cure epidemic hemorrhagic fever, intestinal typhoid fever, influenza, sepsis and so on.
Qi Zhang, Hai-Min Lei, Peng-Long Wang, Zhi-Qiang Ma, Yan Zhang, Jing-Jing Wu, Jing Nie, Su-Juan Chen, Wen-Jie Han, Qing Wang, Dan-Yang Chen, Cheng-Ke Cai, Qiang Li   +12 more
doaj   +1 more source

Truncation and augmentation of level-independent QBD processes

Stochastic Processes and their Applications, 2002
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Latouche, Guy G., Taylor, Peter G.
openaire   +3 more sources

Development of the formulation and manufacturing process of lozenges with Ajania fruticulosa (Ledeb.) Poljak dry extract using the Quality by Design concept

Разработка и регистрация лекарственных средств
Introduction. This article presents the development of a technology for obtaining lozenges containing Ajania fruticulosa dry extract using the direct compression method.
A. M. Jakiyanov, C. I. Ridvanov, Zh. N. Issayev, G. T. Zhumashova, T. S. Bekezhanova, R. I. Kulmanbetov, Y. V. Talgayeva, Zh. Zh. Turuspayeva, Z. B. Sakipova, M. K. Suleimenov   +9 more
doaj   +1 more source

Potential therapeutic effect of Qingwen Baidu Decoction against Corona Virus Disease 2019: a mini review

Chinese Medicine, 2020
The Corona Virus Disease 2019 (COVID-19) is an acute respiratory infectious disease. At present, COVID-19 has no specific therapeutic drugs, and the main clinical treatment is symptomatic treatment and control of complications.
Jianxia Wen, Ruilin Wang, Honghong Liu, Yuling Tong, Shizhang Wei, Xuelin Zhou, Haotian Li, Manyi Jing, Min Wang, Yanling Zhao   +9 more
doaj   +1 more source

Continuous-Time QBD Processes with Continuous Phase Variable [PDF]

, 2006
In this paper, we consider a continuous-time level-dependent QBD process with a continuous phase variable. We extend the censoring technique to be able to deal with the QBD process. We define a new version for the R- and G-measures, and provide two types
Lin, Chuang, Li, Quan-Lin
core   +1 more source

Exploring the potential of carbocisteine loaded microparticulate system by using ccd model for the treatment of respiratory infections

Journal of Applied Pharmaceutical Research
Background: Multi-particulate drug delivery systems (microbeads) deliver drugs over an extended period, distributing them evenly throughout the gastrointestinal tract and minimizing local irritation.
Bhushan R. Rane, Mayur R Gavit, Vaibhav L Patil, Nandini R Mhatre, Ashish S Jain   +4 more
doaj   +1 more source

Analytical QBD Approach to Redefine the Quality of Pharmaceuticals: A Review

Journal of Pharmaceutical Research, 2023
As per the present scenario traditional techniques of quality by testing of finished pharmaceutical products have proved to be unsatisfactory, although focus on 'Total quality assurance can be attained only by in-process testing and analysis ...
Shaik Ayesha Ameen, Nagaraju Pappula
doaj   +1 more source

CSL model checking algorithms for QBDs

Theoretical Computer Science, 2007
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Anne Remke, Boudewijn R. Haverkort, Lucia Cloth   +2 more
openaire   +4 more sources

Integrating Network Pharmacology and Experimental Validation to Explore the Effects and Mechanisms of Qinghao Biejia Decoction and Its Active Compound Artemisinin B Against Non-Small-Cell Lung Cancer

Drug Design, Development and Therapy, 2023
Yonghua Ye,1 Yuping Yang,1 Li Yan,1 Li Zhou,2 Shihui Yu,1 Quan Du,3 Xiaoqiao Dong,3 Qiang Yuan,1 Letian Shan,2,4 Le Guo1 1College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 2The First Affiliated
Ye Y, Yang Y, Yan L, Zhou L, Yu S, Du Q, Dong X, Yuan Q, Shan L, Guo L   +9 more
doaj